BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9641741)

  • 1. Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria.
    Arnold GL; Kramer BM; Kirby RS; Plumeau PB; Blakely EM; Sanger Cregan LS; Davidson PW
    Acta Paediatr; 1998 May; 87(5):565-70. PubMed ID: 9641741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    Behav Genet; 2017 Sep; 47(5):486-497. PubMed ID: 28776207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population.
    Gassió R; Artuch R; Vilaseca MA; Fusté E; Boix C; Sans A; Campistol J
    Dev Med Child Neurol; 2005 Jul; 47(7):443-8. PubMed ID: 15991863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Executive functions in children with phenylketonuria: variations as a function of phenilalanine plasm level].
    Malloy-Diniz LF; Cardoso-Martins C; Carneiro KC; Cerqueira MM; Ferreira AP; Aguiar MJ; Starling AL
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):473-9. PubMed ID: 15273847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities.
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Warwick L; Casanelia S; Anderson VA; Boneh A
    Dev Med Child Neurol; 2004 Apr; 46(4):230-8. PubMed ID: 15077700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive function and psychosocial adjustment in children with early treated phenylketonuria: correlation with historical and concurrent phenylalanine levels.
    Griffiths P; Tarrini M; Robinson P
    J Intellect Disabil Res; 1997 Aug; 41 ( Pt 4)():317-23. PubMed ID: 9297609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylalanine control and family functioning in early-treated phenylketonuria.
    Reber M; Kazak AE; Himmelberg P
    J Dev Behav Pediatr; 1987 Dec; 8(6):311-7. PubMed ID: 3429669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of cognitive functioning in early treated adults with phenylketonuria.
    Hofman DL; Champ CL; Lawton CL; Henderson M; Dye L
    Orphanet J Rare Dis; 2018 Aug; 13(1):150. PubMed ID: 30165883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing is everything: executive functions in children exposed to elevated levels of phenylalanine.
    Antshel KM; Waisbren SE
    Neuropsychology; 2003 Jul; 17(3):458-68. PubMed ID: 12959512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
    Seashore MR; Friedman E; Novelly RA; Bapat V
    Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.
    González García MB; Conde-Guzon P; Alcalde Martín C; Conde-Guzon MJ; Velasco Zúñiga R
    Arch Argent Pediatr; 2017 Jun; 115(3):267-273. PubMed ID: 28504493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test.
    Griffiths P; Campbell R; Robinson P
    J Inherit Metab Dis; 1998 Apr; 21(2):125-35. PubMed ID: 9584263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R; Sullivan K; Young R; McGill J
    Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.